Chronic treatment with an ACE inhibitor, temocapril, lowers the threshold for the infarct size-limiting effect of ischemic preconditioning (Q47263131)

From Wikidata

Jump to navigation Jump to search

scientific article published in April 1999

edit

Language	Label	Description	Also known as
English	Chronic treatment with an ACE inhibitor, temocapril, lowers the threshold for the infarct size-limiting effect of ischemic preconditioning	scientific article published in April 1999

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10372231

retrieved

12 January 2018

reference URL

http://europepmc.org/abstract/MED/10372231

title

Chronic treatment with an ACE inhibitor, temocapril, lowers the threshold for the infarct size-limiting effect of ischemic preconditioning (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10372231

retrieved

12 January 2018

reference URL

http://europepmc.org/abstract/MED/10372231

author name string

Y Nozawa

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10372231

retrieved

12 January 2018

reference URL

http://europepmc.org/abstract/MED/10372231

T Miura

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10372231

retrieved

12 January 2018

reference URL

http://europepmc.org/abstract/MED/10372231

A Tsuchida

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10372231

retrieved

12 January 2018

reference URL

http://europepmc.org/abstract/MED/10372231

H Kita

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10372231

retrieved

12 January 2018

reference URL

http://europepmc.org/abstract/MED/10372231

T Fukuma

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10372231

retrieved

12 January 2018

reference URL

http://europepmc.org/abstract/MED/10372231

K Shimamoto

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10372231

retrieved

12 January 2018

reference URL

http://europepmc.org/abstract/MED/10372231

publication date

1 April 1999

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10372231

retrieved

12 January 2018

reference URL

http://europepmc.org/abstract/MED/10372231

published in

Cardiovascular Drugs and Therapy

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10372231

retrieved

12 January 2018

reference URL

http://europepmc.org/abstract/MED/10372231

volume

13

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10372231

retrieved

12 January 2018

reference URL

http://europepmc.org/abstract/MED/10372231

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10372231

retrieved

12 January 2018

reference URL

http://europepmc.org/abstract/MED/10372231

page(s)

151-157

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10372231

retrieved

12 January 2018

reference URL

http://europepmc.org/abstract/MED/10372231

Identifiers

DOI

10.1023/A:1007744428819

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10372231

retrieved

12 January 2018

reference URL

http://europepmc.org/abstract/MED/10372231

PubMed publication ID

10372231

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10372231

retrieved

12 January 2018

reference URL

http://europepmc.org/abstract/MED/10372231

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47263131&oldid=2148354211"